As of 2025-07-03, the EV/EBITDA ratio of Orthofix Medical Inc (OFIX) is -17.41. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. OFIX's latest enterprise value is 550.67 mil USD. OFIX's TTM EBITDA according to its financial statements is -31.63 mil USD. Dividing these 2 quantities gives us the above OFIX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 10.2x - 16.0x | 12.7x |
| Forward P/E multiples | 10.3x - 23.7x | 15.6x |
| Fair Price | (11.29) - (15.91) | (14.40) |
| Upside | -202.1% - -243.9% | -230.2% |
| Date | EV/EBITDA |
| 2025-06-27 | -17.45 |
| 2025-06-26 | -17.38 |
| 2025-06-25 | -17.17 |
| 2025-06-24 | -17.30 |
| 2025-06-23 | -17.09 |
| 2025-06-20 | -16.51 |
| 2025-06-18 | -16.53 |
| 2025-06-17 | -16.74 |
| 2025-06-16 | -17.25 |
| 2025-06-13 | -17.34 |
| 2025-06-12 | -17.53 |
| 2025-06-11 | -17.81 |
| 2025-06-10 | -18.04 |
| 2025-06-09 | -17.40 |
| 2025-06-06 | -17.30 |
| 2025-06-05 | -16.98 |
| 2025-06-04 | -17.21 |
| 2025-06-03 | -17.37 |
| 2025-06-02 | -17.14 |
| 2025-05-30 | -17.64 |
| 2025-05-29 | -17.68 |
| 2025-05-28 | -17.71 |
| 2025-05-27 | -17.94 |
| 2025-05-23 | -17.46 |
| 2025-05-22 | -17.62 |
| 2025-05-21 | -17.97 |
| 2025-05-20 | -18.56 |
| 2025-05-19 | -18.65 |
| 2025-05-16 | -18.75 |
| 2025-05-15 | -18.82 |
| 2025-05-14 | -18.54 |
| 2025-05-13 | -19.18 |
| 2025-05-12 | -19.11 |
| 2025-05-09 | -18.71 |
| 2025-05-08 | -18.96 |
| 2025-05-07 | -18.60 |
| 2025-05-06 | -18.65 |
| 2025-05-05 | -20.48 |
| 2025-05-02 | -20.79 |
| 2025-05-01 | -20.49 |
| 2025-04-30 | -20.94 |
| 2025-04-29 | -21.21 |
| 2025-04-28 | -21.20 |
| 2025-04-25 | -21.29 |
| 2025-04-24 | -20.99 |
| 2025-04-23 | -20.35 |
| 2025-04-22 | -19.99 |
| 2025-04-21 | -19.71 |
| 2025-04-17 | -19.85 |
| 2025-04-16 | -19.76 |